|
Study | Specimen type | Molecule studied | Methodology | Sample size () | End points | Results | value |
|
Schrohl et al. 2004 [10] | Tumor tissue cytosolic extracts | Protein | ELISA | 2984 | Recurrence-free and overall survival | HR 1.37 HR 1.21 (high versus low levels) |
|
Wu et al. 2008 [6] | Serum and paraffin-embedded tumor tissue | Protein and mRNA | ELISA, IHC and in situ hybridization | 60 | Recurrence-free and overall survival rate | 50% versus 75% 55% versus 88% (high versus low levels) |
|
Nakopoulou et al. 2002 [19] | Paraffin-embedded tumor tissue | mRNA | In situ hybridization | 117 | Overall survival | HR 1.53 (high versus low levels) | |
Nakopoulou et al. 2003 [15] | Paraffin-embedded tumor tissue | Protein | IHC | 133 | Disease-free survival | TIMP-1 overexpression was a favorable prognostic factor. | |
Sieuwerts et al. 2007 [16] | Frozen tumor tissue | mRNA | RT-PCR | 1301 | Metastasis-free survival | HR 0.59 (high versus low levels) | |
Current study | Paraffin-embedded tumor tissue | Protein | IHC | 176 | Recurrence-free and overall survival | HR 1.2 HR 1.73 (high versus low levels) |
|
Snap-frozen tumor tissue | mRNA | Tissue microarray | 176 | Recurrence-free and overall survival | HR 1.6 HR 1.29 (high versus low levels) |
|
|